{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:47:47Z","timestamp":1781552867611,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2019-02294"],"award-info":[{"award-number":["PICT-2019-02294"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009532","name":"Ministerstvo Vnitra \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU21-04-00307"],"award-info":[{"award-number":["NU21-04-00307"]}],"id":[{"id":"10.13039\/100009532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-25349S"],"award-info":[{"award-number":["20-25349S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["UK-22-865742"],"award-info":[{"award-number":["UK-22-865742"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1210176"],"award-info":[{"award-number":["1210176"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00213-022-06170-0","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T20:23:36Z","timestamp":1654719816000},"page":"2841-2852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Natural language signatures of psilocybin microdosing"],"prefix":"10.1007","volume":"239","author":[{"given":"Camila","family":"Sanz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cavanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Zamberlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"Palmucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Janeckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kuchar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Facundo","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo M.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Pallavicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0421-9993","authenticated-orcid":false,"given":"Enzo","family":"Tagliazucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"issue":"5","key":"6170_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s41386-020-0620-4","volume":"45","author":"C Agurto","year":"2020","unstructured":"Agurto C, Cecchi GA, Norel R, Ostrand R, Kirkpatrick M, Baggott MJ, Wardle MC, Wit H, Bedi G (2020) Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing. Neuropsychopharmacology 45(5):823\u2013832. https:\/\/doi.org\/10.1038\/s41386-020-0620-4","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"6170_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12954-019-0308-4","volume":"16","author":"T Anderson","year":"2019","unstructured":"Anderson T, Petranker R, Christopher A, Rosenbaum D, Weissman C, Dinh-Williams LA, Hui K, Hapke E (2019a) Psychedelic microdosing benefits and challenges: an empirical codebook. Harm Reduct J 16(1):43. https:\/\/doi.org\/10.1186\/s12954-019-0308-4","journal-title":"Harm Reduct J"},{"issue":"2","key":"6170_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00213-018-5106-2","volume":"236","author":"T Anderson","year":"2019","unstructured":"Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS (2019b) Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology 236(2):731\u2013740. https:\/\/doi.org\/10.1007\/s00213-018-5106-2","journal-title":"Psychopharmacology"},{"issue":"1","key":"6170_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s42979-021-00958-1","volume":"3","author":"NV Babu","year":"2022","unstructured":"Babu NV, Kanaga EGM (2022) Sentiment analysis in social media data for depression detection using artificial intelligence: a review. SN Comput Sci 3(1):74. https:\/\/doi.org\/10.1007\/s42979-021-00958-1","journal-title":"SN Comput Sci"},{"issue":"10","key":"6170_CR5","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1038\/npp.2014.80","volume":"39","author":"G Bedi","year":"2014","unstructured":"Bedi G, Cecchi GA, Slezak DF, Carrillo F, Sigman M, de Wit H (2014) A window into the intoxicated mind? Speech as an index of psychoactive drug effects. Neuropsychopharmacology 39(10):2340\u20132348. https:\/\/doi.org\/10.1038\/npp.2014.80","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"6170_CR6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.biopsych.2019.05.019","volume":"86","author":"AK Bershad","year":"2019","unstructured":"Bershad AK, Schepers ST, Bremmer MP, Lee R, de Wit H (2019) Acute subjective and behavioral effects of microdoses of lysergic acid diethylamide in healthy human volunteers. Biol Psychiatry 86(10):792\u2013800. https:\/\/doi.org\/10.1016\/j.biopsych.2019.05.019","journal-title":"Biol Psychiatry"},{"issue":"2","key":"6170_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/02791072.2020.1718250","volume":"52","author":"LP Cameron","year":"2020","unstructured":"Cameron LP, Nazarian A, Olson DE (2020) Psychedelic microdosing: prevalence and subjective effects. J Psychoactive Drugs 52(2):113\u2013122. https:\/\/doi.org\/10.1080\/02791072.2020.1718250","journal-title":"J Psychoactive Drugs"},{"key":"6170_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","volume":"8","author":"RL Carhart-Harris","year":"2014","unstructured":"Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D (2014) The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci 8:20. https:\/\/doi.org\/10.3389\/fnhum.2014.00020","journal-title":"Front Hum Neurosci"},{"key":"6170_CR9","doi-asserted-by":"crossref","unstructured":"Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi ER (2022) Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity. Biorxiv","DOI":"10.1101\/2021.11.30.470657"},{"issue":"1","key":"6170_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/wps.20491","volume":"17","author":"CM Corcoran","year":"2018","unstructured":"Corcoran CM, Carrillo F, Fernandez-Slezak D, Bedi G, Klim C, Javitt DC, Bearden CE, Cecchi GA (2018) Prediction of psychosis across protocols and risk cohorts using automated language analysis. World Psychiatry 17(1):67\u201375. https:\/\/doi.org\/10.1002\/wps.20491","journal-title":"World Psychiatry"},{"issue":"4","key":"6170_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/00952990.2021.1910830","volume":"47","author":"DJ Cox","year":"2021","unstructured":"Cox DJ, Garcia-Romeu A, Johnson MW (2021) Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives. Am J Drug Alcohol Abuse 47(4):444\u2013454. https:\/\/doi.org\/10.1080\/00952990.2021.1910830","journal-title":"Am J Drug Alcohol Abuse"},{"key":"6170_CR12","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000404","author":"DJ Cox","year":"2021","unstructured":"Cox DJ, Johnson MW (2021) Verbal behavior related to drug reinforcement in polysubstance cannabis users: comparison across drugs. Exp Clin Psychopharmacol. https:\/\/doi.org\/10.1037\/pha0000404","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1\u20133","key":"6170_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.schres.2007.03.001","volume":"93","author":"B Elvevag","year":"2007","unstructured":"Elvevag B, Foltz PW, Weinberger DR, Goldberg TE (2007) Quantifying incoherence in speech: an automated methodology and novel application to schizophrenia. Schizophr Res 93(1\u20133):304\u2013316. https:\/\/doi.org\/10.1016\/j.schres.2007.03.001","journal-title":"Schizophr Res"},{"issue":"2","key":"6170_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/02791072.2019.1593561","volume":"51","author":"J Fadiman","year":"2019","unstructured":"Fadiman J, Korb S (2019) Might microdosing psychedelics be safe and beneficial? An Initial Exploration. J Psychoactive Drugs 51(2):118\u2013122. https:\/\/doi.org\/10.1080\/02791072.2019.1593561","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"6170_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","volume":"237","author":"N Family","year":"2020","unstructured":"Family N, Maillet EL, Williams LTJ, Krediet E, Carhart-Harris RL, Williams TM, Nichols CD, Goble DJ, Raz S (2020) Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers. Psychopharmacology 237(3):841\u2013853. https:\/\/doi.org\/10.1007\/s00213-019-05417-7","journal-title":"Psychopharmacology"},{"key":"6170_CR16","doi-asserted-by":"publisher","first-page":"116726","DOI":"10.1016\/j.neuroimage.2020.116726","volume":"213","author":"M Girn","year":"2020","unstructured":"Girn M, Mills C, Roseman L, Carhart-Harris RL, Christoff K (2020) Updating the dynamic framework of thought: creativity and psychedelics. Neuroimage 213:116726. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.116726","journal-title":"Neuroimage"},{"issue":"2","key":"6170_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/dta.2950","volume":"13","author":"K Gotvaldova","year":"2021","unstructured":"Gotvaldova K, Hajkova K, Borovicka J, Jurok R, Cihlarova P, Kuchar M (2021) Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis. Drug Test Anal 13(2):439\u2013446. https:\/\/doi.org\/10.1002\/dta.2950","journal-title":"Drug Test Anal"},{"issue":"1","key":"6170_CR18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1609\/icwsm.v6i1.14322","volume":"6","author":"A Hannak","year":"2012","unstructured":"Hannak A, Anderson E, Barrett LF, Lehmann S, Mislove A, Riedewald M (2012) Tweetin\u2019in the rain: Exploring societal-scale effects of weather on mood. In Proceedings of the International AAAI Conference on Web and Social Media 6(1):479\u2013482","journal-title":"In Proceedings of the International AAAI Conference on Web and Social Media"},{"key":"6170_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00213-022-06062-3","volume":"239","author":"A Hase","year":"2022","unstructured":"Hase A, Erdmann M, Limbach V, Hasler G (2022) Analysis of recreational psychedelic substance use experiences classified by substance. Psychopharmacology 239:643\u2013659","journal-title":"Psychopharmacology"},{"issue":"7","key":"6170_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/ijnp\/pyz029","volume":"22","author":"N Hutten","year":"2019","unstructured":"Hutten N, Mason NL, Dolder PC, Kuypers KPC (2019a) Motives and side-effects of microdosing with psychedelics among users. Int J Neuropsychopharmacol 22(7):426\u2013434. https:\/\/doi.org\/10.1093\/ijnp\/pyz029","journal-title":"Int J Neuropsychopharmacol"},{"key":"6170_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fpsyt.2019.00672","volume":"10","author":"N Hutten","year":"2019","unstructured":"Hutten N, Mason NL, Dolder PC, Kuypers KPC (2019b) Self-rated effectiveness of microdosing with psychedelics for mental and physical health problems among microdosers. Front Psychiatry 10:672. https:\/\/doi.org\/10.3389\/fpsyt.2019.00672","journal-title":"Front Psychiatry"},{"key":"6170_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.euroneuro.2020.10.002","volume":"41","author":"N Hutten","year":"2020","unstructured":"Hutten N, Mason NL, Dolder PC, Theunissen EL, Holze F, Liechti ME, Feilding A, Ramaekers JG, Kuypers KPC (2020) Mood and cognition after administration of low LSD doses in healthy volunteers: a placebo controlled dose-effect finding study. Eur Neuropsychopharmacol 41:81\u201391. https:\/\/doi.org\/10.1016\/j.euroneuro.2020.10.002","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"6170_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1455072517753339","volume":"35","author":"PG Johnstad","year":"2018","unstructured":"Johnstad PG (2018) Powerful substances in tiny amounts: an interview study of psychedelic microdosing. Nordisk Alkohol Nark 35(1):39\u201351. https:\/\/doi.org\/10.1177\/1455072517753339","journal-title":"Nordisk Alkohol Nark"},{"issue":"1","key":"6170_CR24","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/s41598-021-81446-7","volume":"11","author":"LS Kaertner","year":"2021","unstructured":"Kaertner LS, Steinborn MB, Kettner H, Spriggs MJ, Roseman L, Buchborn T, Balaet M, Timmermann C, Erritzoe D, Carhart-Harris RL (2021) Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing. Sci Rep 11(1):1941. https:\/\/doi.org\/10.1038\/s41598-021-81446-7","journal-title":"Sci Rep"},{"issue":"9","key":"6170_CR25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/0269881119857204","volume":"33","author":"KP Kuypers","year":"2019","unstructured":"Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D (2019) Microdosing psychedelics: more questions than answers? An overview and suggestions for future research. J Psychopharmacol 33(9):1039\u20131057. https:\/\/doi.org\/10.1177\/0269881119857204","journal-title":"J Psychopharmacol"},{"key":"6170_CR26","doi-asserted-by":"publisher","first-page":"204512532095056","DOI":"10.1177\/2045125320950567","volume":"10","author":"KPC Kuypers","year":"2020","unstructured":"Kuypers KPC (2020) The therapeutic potential of microdosing psychedelics in depression. Ther Adv Psychopharmacol 10:2045125320950567. https:\/\/doi.org\/10.1177\/2045125320950567","journal-title":"Ther Adv Psychopharmacol"},{"issue":"2","key":"6170_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/02791072.2019.1683260","volume":"52","author":"T Lea","year":"2020","unstructured":"Lea T, Amada N, Jungaberle H (2020a) Psychedelic microdosing: a subreddit analysis. J Psychoactive Drugs 52(2):101\u2013112. https:\/\/doi.org\/10.1080\/02791072.2019.1683260","journal-title":"J Psychoactive Drugs"},{"key":"6170_CR28","doi-asserted-by":"publisher","first-page":"102600","DOI":"10.1016\/j.drugpo.2019.11.008","volume":"75","author":"T Lea","year":"2020","unstructured":"Lea T, Amada N, Jungaberle H, Schecke H, Klein M (2020b) Microdosing psychedelics: motivations, subjective effects and harm reduction. Int J Drug Policy 75:102600. https:\/\/doi.org\/10.1016\/j.drugpo.2019.11.008","journal-title":"Int J Drug Policy"},{"issue":"5","key":"6170_CR29","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00213-020-05477-0","volume":"237","author":"T Lea","year":"2020","unstructured":"Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M (2020c) Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders. Psychopharmacology 237(5):1521\u20131532. https:\/\/doi.org\/10.1007\/s00213-020-05477-0","journal-title":"Psychopharmacology"},{"issue":"9","key":"6170_CR30","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/17512433.2021.1933434","volume":"14","author":"SD Muthukumaraswamy","year":"2021","unstructured":"Muthukumaraswamy SD, Forsyth A, Lumley T (2021) Blinding and expectancy confounds in psychedelic randomized controlled trials. Expert Rev Clin Pharmacol 14(9):1133\u20131152. https:\/\/doi.org\/10.1080\/17512433.2021.1933434","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6170_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41531-020-0113-5","volume":"6","author":"R Norel","year":"2020","unstructured":"Norel R, Agurto C, Heisig S, Rice JJ, Zhang H, Ostrand R, Wacnik PW, Ho BK, Ramos VL, Cecchi GA (2020) Speech-based characterization of dopamine replacement therapy in people with Parkinson\u2019s disease. NPJ Parkinsons Dis 6:12. https:\/\/doi.org\/10.1038\/s41531-020-0113-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"6170_CR32","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00213-020-05464-5","volume":"237","author":"JA Olson","year":"2020","unstructured":"Olson JA, Suissa-Rocheleau L, Lifshitz M, Raz A, Veissiere SPL (2020) Tripping on nothing: placebo psychedelics and contextual factors. Psychopharmacology 237(5):1371\u20131382. https:\/\/doi.org\/10.1007\/s00213-020-05464-5","journal-title":"Psychopharmacology"},{"key":"6170_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.neubiorev.2020.09.035","volume":"119","author":"G Ona","year":"2020","unstructured":"Ona G, Bouso JC (2020) Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: a systematic review. Neurosci Biobehav Rev 119:194\u2013203. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.09.035","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"6170_CR34","doi-asserted-by":"publisher","first-page":"e0211023","DOI":"10.1371\/journal.pone.0211023","volume":"14","author":"V Polito","year":"2019","unstructured":"Polito V, Stevenson RJ (2019) A systematic study of microdosing psychedelics. PLoS One 14(2):e0211023. https:\/\/doi.org\/10.1371\/journal.pone.0211023","journal-title":"PLoS One"},{"key":"6170_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.landurbplan.2019.04.024","volume":"189","author":"RA Plunz","year":"2019","unstructured":"Plunz RA et al (2019) Twitter sentiment in New York City parks as measure of well being. Landsc Urban Plan 189:235\u2013246","journal-title":"Landsc Urban Plan"},{"issue":"12","key":"6170_CR36","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00213-018-5049-7","volume":"235","author":"L Prochazkova","year":"2018","unstructured":"Prochazkova L, Lippelt DP, Colzato LS, Kuchar M, Sjoerds Z, Hommel B (2018) Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting. Psychopharmacology 235(12):3401\u20133413. https:\/\/doi.org\/10.1007\/s00213-018-5049-7","journal-title":"Psychopharmacology"},{"key":"6170_CR37","doi-asserted-by":"crossref","unstructured":"Qiu TT, Minda JP (2021) Recreational psychedelic users frequently encounter complete mystical experiences: trip content and implications for wellbeing. psyarxiv","DOI":"10.31234\/osf.io\/xrbzs"},{"issue":"1","key":"6170_CR38","doi-asserted-by":"publisher","first-page":"22479","DOI":"10.1038\/s41598-021-01811-4","volume":"11","author":"JM Rootman","year":"2021","unstructured":"Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Polito V, Bourzat F, Walsh Z (2021) Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. Sci Rep 11(1):22479. https:\/\/doi.org\/10.1038\/s41598-021-01811-4","journal-title":"Sci Rep"},{"key":"6170_CR39","volume-title":"Fundamentals of","author":"B Rosner","year":"2016","unstructured":"Rosner B (2016) Fundamentals of, biostatistics. Cengage Learning, Boston, MA","edition":"biostatistics"},{"key":"6170_CR40","first-page":"e12276","volume":"14","author":"C Sanz","year":"2022","unstructured":"Sanz C, Carrillo F, Slachevsky A, Forno G, Gorno Tempini ML, Villagra R, Iba\u00f1ez A, Tagliazucchi E, Garc\u00eda AM (2022) Automated text-level semantic markers of Alzheimer\u2019s disease. Alzheimer Dement Diagn Assess Dis Monit 14:e12276","journal-title":"Alzheimer Dement Diagn Assess Dis Monit"},{"key":"6170_CR41","doi-asserted-by":"publisher","first-page":"103070","DOI":"10.1016\/j.concog.2020.103070","volume":"87","author":"C Sanz","year":"2021","unstructured":"Sanz C, Pallavicini C, Carrillo F, Zamberlan F, Sigman M, Mota N, Copelli M, Ribeiro S, Nutt D, Carhart-Harris R, Tagliazucchi E (2021) The entropic tongue: disorganization of natural language under LSD. Conscious Cogn 87:103070. https:\/\/doi.org\/10.1016\/j.concog.2020.103070","journal-title":"Conscious Cogn"},{"key":"6170_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fnins.2018.00007","volume":"12","author":"C Sanz","year":"2018","unstructured":"Sanz C, Zamberlan F, Erowid E, Erowid F, Tagliazucchi E (2018) The experience elicited by hallucinogens presents the highest similarity to dreaming within a large database of psychoactive substance reports. Front Neurosci 12:7. https:\/\/doi.org\/10.3389\/fnins.2018.00007","journal-title":"Front Neurosci"},{"issue":"10","key":"6170_CR43","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/17512433.2021.1951473","volume":"14","author":"EE Schenberg","year":"2021","unstructured":"Schenberg EE (2021) Who is blind in psychedelic research? Letter to the editor regarding: blinding and expectancy confounds in psychedelic randomized controlled trials. Expert Rev Clin Pharmacol 14(10):1317\u20131319. https:\/\/doi.org\/10.1080\/17512433.2021.1951473","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6170_CR44","doi-asserted-by":"crossref","unstructured":"Schwartz HA, Sap M, Kern ML, Eichstaedt JC, Kapelner A, Agrawal M, Blanco E, Dziurzynski L, Park G, Stillwell D, Kosinski M, Seligman ME, Ungar LH (2016) Predicting individual well-being through the language of social media. Pac Symp Biocomput 21:516\u2013527. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26776214","DOI":"10.1142\/9789814749411_0047"},{"key":"6170_CR45","doi-asserted-by":"publisher","unstructured":"Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D (2021) Self-blinding citizen science to explore psychedelic microdosing. Elife. https:\/\/doi.org\/10.7554\/eLife.62878","DOI":"10.7554\/eLife.62878"},{"key":"6170_CR46","doi-asserted-by":"crossref","unstructured":"Tagliazucchi E (2022) Natural language as a window into the subjective effects and neurochemistry of psychedelic drugs.\u00a0Frontiers in Pharmacology 900","DOI":"10.20944\/preprints202111.0201.v1"},{"key":"6170_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05857-0","author":"M van Elk","year":"2021","unstructured":"van Elk M, Fejer G, Lempe P, Prochazckova L, Kuchar M, Hajkova K, Marschall J (2021) Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study. Psychopharmacology. https:\/\/doi.org\/10.1007\/s00213-021-05857-0","journal-title":"Psychopharmacology"},{"key":"6170_CR48","doi-asserted-by":"crossref","unstructured":"Wie\u00dfner I, Falchi M, Palhano-Fontes F, Oliveira Maia L, Feilding A, Ribeiro S, Mota N, Barros de Araujo D, T\u00f3foli LF (2021) Low-dose LSD and the stream of thought: increased discontinuity of mind, deep thoughts and abstract flow. Psychopharmacology 39:1721\u20131733","DOI":"10.1007\/s00213-021-06006-3"},{"issue":"4","key":"6170_CR49","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00213-018-5119-x","volume":"236","author":"S Yanakieva","year":"2019","unstructured":"Yanakieva S, Polychroni N, Family N, Williams LTJ, Luke DP, Terhune DB (2019) The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial. Psychopharmacology 236(4):1159\u20131170. https:\/\/doi.org\/10.1007\/s00213-018-5119-x","journal-title":"Psychopharmacology"},{"key":"6170_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fnint.2018.00054","volume":"12","author":"F Zamberlan","year":"2018","unstructured":"Zamberlan F, Sanz C, Martinez Vivot R, Pallavicini C, Erowid F, Erowid E, Tagliazucchi E (2018) The varieties of the psychedelic experience: a preliminary study of the association between the reported subjective effects and the binding affinity profiles of substituted phenethylamines and tryptamines. Front Integr Neurosci 12:54. https:\/\/doi.org\/10.3389\/fnint.2018.00054","journal-title":"Front Integr Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06170-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06170-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06170-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T14:22:54Z","timestamp":1675779774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06170-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["6170"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06170-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.20.481177","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"28 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}